Annual Report 2024

CONSOLIDATED STATEMENT OF FINANCIAL POSITION At 31 December 2024 47 The United Laboratories International Holdings Limited Annual Report 2024 2024 2023 NOTES RMB’000 RMB’000 Non-current liabilities Deferred tax liabilities 30 282,492 288,080 Deferred income in respect of government grants 26 & 34 22,205 32,237 Derivative financial instruments 36 – 19,191 Lease liabilities 28 12,667 4,322 Borrowings – due after one year 29 2,307,899 1,299,000 2,625,263 1,642,830 Net assets 14,435,240 12,747,618 Capital and reserves Share capital 31 16,965 16,965 Reserves 14,371,318 12,717,813 Equity attributable to owners of the Company 14,388,283 12,734,778 Non-controlling interests 46,957 12,840 Total equity 14,435,240 12,747,618 The consolidated financial statements on pages 44 to 151 were approved and authorised for issue by the Board of Directors on 24 March 2025 and are signed on its behalf by: TSOI HOI SHAN LEUNG WING HON DIRECTOR DIRECTOR